Clinical Trial: Inclisiran (Leqvio(R)) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958315) titled 'Inclisiran (Leqvio(R)) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study' on April 25.

Brief Summary: This study aims to address several key questions regarding the use of inclisiran in real-world clinical practice in Spain.

Study Start Date: April 30

Study Type: OBSERVATIONAL

Condition: Atherosclerotic Vascular Disease Heterozygous Familial Hypercholesterolemia

Intervention: OTHER: Inclisiran

This is an observational study, there is no treatment allocation.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Disclaimer...